Plain-language US guide

Question desk · A calm first pass

What does care actually involve?

A regenerative treatment center visit is still a health visit. The clinician needs enough information to decide whether remote care, an exam, tests or a referral fit the situation.

Before the visit

The useful questions are simple and direct.

Bring the product name, a current medicine list, the main concern and the questions that matter most. Leave room for “this is not a fit” to be a possible answer.

Does the first visit have to be in person?

Not always. As of September 2026, federal law does not require an in-person visit for ordinary prescription medicines that are not controlled substances. State rules still apply, and the clinician must provide the same quality of care as during an office visit. The Finding care page links to the state medical board directory.

Can an online form count as a visit?

Sometimes. A medical-board model policy—an example for state boards, not a law by itself—says an online visit may count when you and the clinician can exchange questions, enough health information is gathered and follow-up is possible. A fixed tick-box form with no meaningful questions back is not the same thing.

Are blood tests always required?

No general federal rule requires blood tests before every prescription. The product, the health question and state rules can change what the clinician needs to ask, examine or test.

What if an exam or test is needed?

Medical-board policy says the clinician must arrange needed testing or refer the patient when remote care cannot supply what the assessment requires.

Is care by phone or video held to a lower standard?

No. Medical-board policy holds care over a screen to the same professional quality required for care in a room.

What if the treatment appears as a menu?

That is a reason to slow down. The Federation of State Medical Boards (the umbrella body for every state’s medical board) warned in May 2026 that picking from a treatment menu without a real health assessment does not meet the expected quality of care. Its statement is advice, not a new federal law.

During the visit

Listen for the questions coming back.

A real assessment is not a checkout flow. It makes space for history, uncertainty, alternatives and a reason to pause.

  • What is the main problem, and what has already been tried?
  • What medicines, supplements and allergies are in the picture?
  • What outcome would count as useful, and how would it be measured?
  • What could make this product a poor fit?
  • What happens if symptoms change or a problem appears?

Before saying yes

Ask for the plan in plain words.

The product

What is its exact name? Is the finished product approved or compounded? Who makes it?

The reason

What is the clinician trying to treat, and why is this option in the conversation?

The check-in

Who reviews progress, how can questions be raised, and what would lead to a change in plan?

The exit

What happens if the medicine is not useful, is too costly or causes a problem?